华法林患者不良事件治疗路径数据集

数据集获取（Figshare）

• 源站标题：Therapeutic itinerary: trajectory for resolution of adverse events of patients using warfarin in Southern Brazil
• DOI：10.6084/m9.figshare.7419134.v1
• 发布日期：2018-12-05
• 文件数：4 个
• 文件总体积：363.33 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Therapeutic_itinerary_trajectory_for_resolution_of_adverse_events_of_patients_using_warfarin_in_Southern_Brazil/7419134

命令行下载

curl -L -o "a52ee36e526d9969f8b0df12fbe3e651d22cd12d.jpg" "https://ndownloader.figshare.com/files/35810121"
curl -L -o "aca40a9bb78749d09d5da8a3430cd1b195288110.jpg" "https://ndownloader.figshare.com/files/35810124"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/35810127"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/35810130"

文件清单

• a52ee36e526d9969f8b0df12fbe3e651d22cd12d.jpg（163.20 KB）
• aca40a9bb78749d09d5da8a3430cd1b195288110.jpg（188.86 KB）
• Table_1.xls（5.63 KB）
• Table_2.xls（5.63 KB）

文件总体积 363.33 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Warfarin is the most used anticoagulant in primary health care. Due to the narrow therapeutic index, its users are more susceptible to adverse events. The objective of this study was to describe the itinerary of the public health sector patients for resolution of adverse events related to warfarin. It is a prospective open cohort, held for a period of 18 months with warfarin users of the Brazilian public health system. Data were collected by monthly interviews and from patient records. Results: Sixty nine patients were interviewed, 64 of them completed monitoring and five died. Bleeding and venous thromboembolism were more frequent in patients starting treatment. It was observed that when adverse events have occurred, in most cases the patient held self-care at home (57%). During the follow-up, five patients were hospitalized for bleeding. Approximately half of the patients did not present their INR exams to the doctor. Conclusions: This study demonstrates weaknesses in caring for these patients and the need to accompany them, aiming to standardize and guide the itinerary of the anticoagulated patient to solve their problems and improve safety in drug treatment, with less cost to the public health system.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.7419134.v1（source: https://scielo.figshare.com/articles/dataset/Therapeutic_itinerary_trajectory_for_resolution_of_adverse_events_of_patients_using_warfarin_in_Southern_Brazil/7419134）。